514 related articles for article (PubMed ID: 17109645)
21. How to deal with multiple treatment or dose groups in randomized clinical trials?
Hothorn LA
Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
[TBL] [Abstract][Full Text] [Related]
22. Design and analysis issues of multiregional clinical trials with different regional primary endpoints.
Tsou HH; Tsong Y; Chang WJ; Dong X; Hsiao CF
J Biopharm Stat; 2012 Sep; 22(5):1051-9. PubMed ID: 22946949
[TBL] [Abstract][Full Text] [Related]
23. Analysis strategies for adaptive designs with multiple endpoints.
Chang M; Chow SC
J Biopharm Stat; 2007; 17(6):1189-200. PubMed ID: 18027225
[TBL] [Abstract][Full Text] [Related]
24. A note on one-sided tests with multiple endpoints.
Perlman MD; Wu L
Biometrics; 2004 Mar; 60(1):276-9; discussion 279-80. PubMed ID: 15032799
[TBL] [Abstract][Full Text] [Related]
25. Two-stage designs for dose-finding trials with a biologic endpoint using stepwise tests.
Polley MY; Cheung YK
Biometrics; 2008 Mar; 64(1):232-41. PubMed ID: 17573866
[TBL] [Abstract][Full Text] [Related]
26. Method of balanced adjustment in testing co-primary endpoints.
Kordzakhia G; Siddiqui O; Huque MF
Stat Med; 2010 Aug; 29(19):2055-66. PubMed ID: 20683896
[TBL] [Abstract][Full Text] [Related]
27. Bonferroni-based correction factor for multiple, correlated endpoints.
Shi Q; Pavey ES; Carter RE
Pharm Stat; 2012; 11(4):300-9. PubMed ID: 22588983
[TBL] [Abstract][Full Text] [Related]
28. Statistical tests based on new composite hypotheses in clinical trials reflecting the relative clinical importance of multiple endpoints quantitatively.
Nishikawa M; Tango T; Ohtaki M
Biom J; 2009 Oct; 51(5):749-62. PubMed ID: 19777463
[TBL] [Abstract][Full Text] [Related]
29. Some issues with composite endpoints in clinical trials.
Chi GY
Fundam Clin Pharmacol; 2005 Dec; 19(6):609-19. PubMed ID: 16313272
[TBL] [Abstract][Full Text] [Related]
30. Challenge of multiple co-primary endpoints: a new approach.
Chuang-Stein C; Stryszak P; Dmitrienko A; Offen W
Stat Med; 2007 Mar; 26(6):1181-92. PubMed ID: 16927251
[TBL] [Abstract][Full Text] [Related]
31. Hierarchical testing of multiple endpoints in group-sequential trials.
Glimm E; Maurer W; Bretz F
Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
[TBL] [Abstract][Full Text] [Related]
32. Superiority inferences on individual endpoints following noninferiority testing in clinical trials.
Logan BR; Tamhane AC
Biom J; 2008 Oct; 50(5):693-703. PubMed ID: 18932132
[TBL] [Abstract][Full Text] [Related]
33. Addressing multiplicity issues of a composite endpoint and its components in clinical trials.
Huque MF; Alosh M; Bhore R
J Biopharm Stat; 2011 Jul; 21(4):610-34. PubMed ID: 21516560
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the statistical power for multiple tests: a case study.
Yeo A; Qu Y
Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
[TBL] [Abstract][Full Text] [Related]
35. Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures.
Bretz F; Maurer W; Hommel G
Stat Med; 2011 Jun; 30(13):1489-501. PubMed ID: 21290405
[TBL] [Abstract][Full Text] [Related]
36. Multiple comparisons in complex clinical trial designs.
Hung HM; Wang SJ
Biom J; 2013 May; 55(3):420-9. PubMed ID: 23620458
[TBL] [Abstract][Full Text] [Related]
37. Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.
Quan H; Luo X; Capizzi T
Stat Med; 2005 Jul; 24(14):2151-70. PubMed ID: 15909290
[TBL] [Abstract][Full Text] [Related]
38. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
39. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
40. What we want versus what we can get: a closer look at failure time endpoints for cardiovascular studies.
Song R; Cook TD; Kosorok MR
J Biopharm Stat; 2008; 18(2):370-81. PubMed ID: 18327727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
